Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2007 3
2008 7
2009 8
2010 7
2011 3
2012 1
2013 1
2014 2
2015 6
2016 2
2017 3
2018 3
2019 5
2020 3
2021 3
2022 1
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Differences in social media use by COVID-19 vaccination status.
Moffett KW, Seserman K, Margolis KA, Kranzler EC, Marshall MC, Dahlen H, Kim JC, Denison B, Hoffman B, Dupervil D, Yu K, Hoffman L. Moffett KW, et al. Vaccine. 2024 Apr 2;42(9):2166-2170. doi: 10.1016/j.vaccine.2024.03.031. Epub 2024 Mar 20. Vaccine. 2024. PMID: 38514356 Free article.
Staphylococcus argenteus bacteremia in the Republic of Korea.
Lee M, Choi Y, Choi SJ, Moon SM, Kim ES, Kim HB, Ahn S, Lee H, Kim J, Shin DW, Yeom J, Park JS, Song K-H. Lee M, et al. Among authors: kim j. Microbiol Spectr. 2024 Feb 6;12(2):e0279823. doi: 10.1128/spectrum.02798-23. Epub 2024 Jan 10. Microbiol Spectr. 2024. PMID: 38197655 Free PMC article.
Benefit-Cost Analysis of the HHS COVID-19 Campaign: April 2021-March 2022.
Turner S, Kranzler EC, Trigger S, Kearsley A, Luchman JN, Williams CJ, Denison B, Dahlen H, Kim JC, Bennett M, Nighbor T, Beleche T, Hoffman L, Peck J. Turner S, et al. Am J Prev Med. 2024 Apr 22:S0749-3797(24)00110-7. doi: 10.1016/j.amepre.2024.03.018. Online ahead of print. Am J Prev Med. 2024. PMID: 38713123 Free article.
Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial.
Leem G, Jang SI, Cho JH, Jo JH, Lee HS, Chung MJ, Park JY, Bang S, Yoo DK, Cheon HC, Kim JE, Lim KP, Jung IH, Im JM, Chung YY, Park SW. Leem G, et al. Cancers (Basel). 2022 Aug 30;14(17):4229. doi: 10.3390/cancers14174229. Cancers (Basel). 2022. PMID: 36077766 Free PMC article.
67 results